Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L King

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
Plos Neglected Tropical Diseases|July 18, 2019
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approachCharles W Goss, Katiuscia O'Brian, Christine Dubray, et al.
Malaria Journal|May 28, 2016
Adhesion of Plasmodium falciparum infected erythrocytes in ex vivo perfused placental tissue: a novel model of placental malariaCaroline Pehrson, Line Mathiesen, Kristine K Heno, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Plos Neglected Tropical Diseases|May 17, 2016
An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical ProtectionCamila T França, Jessica B Hostetler, Sumana Sharma, et al.
Scientific Reports|October 25, 2017
An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodiesFrancis B Ntumngia, Camilla V Pires, Samantha J Barnes, et al.
Vaccines|November 25, 2023
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of ProtectionKimia Sobhani, Susan Cheng, Raquel A Binder, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2010
Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy peopleDidier Ménard, Céline Barnadas, Christiane Bouchier, et al.
Malaria Journal|April 30, 2017
Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western ThailandRhea J Longley, Camila T França, Michael T White, et al.
Infection and Immunity|November 26, 2014
Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseDanielle I Stanisic, Freya J I Fowkes, Melanie Koinari, et al.
Plos Neglected Tropical Diseases|February 16, 2019
Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical MalariaWen-Qiang He, Ahmad Rushdi Shakri, Rukmini Bhardwaj, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
Plos Neglected Tropical Diseases|July 18, 2019
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approachCharles W Goss, Katiuscia O'Brian, Christine Dubray, et al.
Malaria Journal|May 28, 2016
Adhesion of Plasmodium falciparum infected erythrocytes in ex vivo perfused placental tissue: a novel model of placental malariaCaroline Pehrson, Line Mathiesen, Kristine K Heno, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Plos Neglected Tropical Diseases|May 17, 2016
An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical ProtectionCamila T França, Jessica B Hostetler, Sumana Sharma, et al.
Scientific Reports|October 25, 2017
An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodiesFrancis B Ntumngia, Camilla V Pires, Samantha J Barnes, et al.
Vaccines|November 25, 2023
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of ProtectionKimia Sobhani, Susan Cheng, Raquel A Binder, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2010
Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy peopleDidier Ménard, Céline Barnadas, Christiane Bouchier, et al.
Malaria Journal|April 30, 2017
Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western ThailandRhea J Longley, Camila T França, Michael T White, et al.
Infection and Immunity|November 26, 2014
Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseDanielle I Stanisic, Freya J I Fowkes, Melanie Koinari, et al.
Plos Neglected Tropical Diseases|February 16, 2019
Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical MalariaWen-Qiang He, Ahmad Rushdi Shakri, Rukmini Bhardwaj, et al.
Pageof 18